AVIR: Atea Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 256.58
Enterprise Value ($M) 191.88
Book Value ($M) 438.87
Book Value / Share 5.13
Price / Book 0.58
NCAV ($M) 436.55
NCAV / Share 5.10
Price / NCAV 0.59

Profitability (mra)
Return on Invested Capital (ROIC) -0.38
Return on Assets (ROA) -0.30
Return on Equity (ROE) -0.33

Liquidity (mrq)
Quick Ratio 24.85
Current Ratio 24.85

Balance Sheet (mrq) ($M)
Current Assets 462.36
Assets 464.67
Liabilities 25.80
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -132.22
Net Income -168.38

Cash Flow Statement (mra) ($M)
Cash From Operations -135.50
Cash from Investing 56.10
Cash from Financing 0.27

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
2 days ago 13D/A Radoff Family Foundation 4.00 8.86
02-14 13G/A EcoR1 Capital, LLC 4.00 -38.59
12-16 13D BML Investment Partners, L.P. 8.50 28.81
11-12 13G/A Fmr Llc 7.84 23.69

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-06 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 173,802 1,513,038 11.49
2025-04-16 99,365 400,123 24.83
2025-04-15 38,996 327,256 11.92
2025-04-14 52,141 329,494 15.82

(click for more detail)

Similar Companies
ARWR – Arrowhead Pharmaceuticals, Inc. ASMB – Assembly Biosciences, Inc.
ATRA – Atara Biotherapeutics, Inc. AVXL – Anavex Life Sciences Corp.
BBIO – BridgeBio Pharma, Inc.


Financial data and stock pages provided by
Fintel.io

Finpedia: Aviragen Therapeutics